Study identifier:NIS-OCN-ZOL-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A Non-interventional Study of postoperative treatment with Goserelin acetate (Zoladex) in moderate to severe endometriosis patient
endometriosis
-
No
-
Female
408
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Apr 2014 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
This is a prospective, open label NIS, which is to assess the efficacy of Zoladex in adjuvant setting after operation in moderate to severe endometriosis patients.
Location
Location
Beijing, Beijing, China
Location
Shenyang, Liaoning, China
Location
Harbin, Heilongjiang, China
Location
Hangzhou, Zhejiang, China
Location
Chengdu, Sichuan, China
Location
Changsha, Hunan, China
Location
Shenzhen, Guangdong, China
Location
Guangzhou, Guangdong, China
Arms | Assigned Interventions |
---|
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.